Neomycin And Polymyxin B Sulfates And Bacitracin Zinc Ointment
NDC Package 24208-780-55

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Neomycin And Polymyxin B Sulfates And Bacitracin Zinc (neomycin sulfate, polymyxin b sulfate and bacitracin zinc) ointment is neomycin and polymyxin B sulfates and bacitracin zinc ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. This formulation utilizes a ointment delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-780 and is authorized under FDA application ANDA064064.

Identification & Billing

NDC Package Code
24208-780-55
Package Description
1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
Product Code
24208-780
11-Digit Billing Format
24208078055
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
3.5 GM
RxNorm Crosswalk
  • RxCUI: 308493 - bacitracin zinc 400 UNT / neomycin sulfate 3.5 MG / polymyxin B sulfate 10,000 UNT per GM Ophthalmic Ointment
  • RxCUI: 308493 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment
  • RxCUI: 308493 - bacitracin 0.4 UNT/MG / neomycin 0.35 % / polymyxin B 10 UNT/MG Ophthalmic Ointment
  • RxCUI: 308493 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM Ophthalmic Ointment

Clinical Specifications

Proprietary Name
Neomycin And Polymyxin B Sulfates And Bacitracin Zinc
Non-Proprietary Name
Neomycin Sulfate, Polymyxin B Sulfate And Bacitracin Zinc
Substance Name
Bacitracin Zinc; Neomycin Sulfate; Polymyxin B Sulfate
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Neomycin and polymyxin B sulfates and bacitracin zinc ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.

Regulatory & Marketing

Labeler Name
Bausch & Lomb Incorporated
Product Type
Human Prescription Drug
FDA Application #
ANDA064064
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-30-1995
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24208-780-55 identifies a specific commercial package of 1 tube in 1 carton / 3.5 g in 1 tube of Neomycin And Polymyxin B Sulfates And Bacitracin Zinc, a human prescription drug labeled by Bausch & Lomb Incorporated. This ointment is formulated for ophthalmic use and contains bacitracin zinc; neomycin sulfate; polymyxin b sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on October 30, 1995. The current certification is valid through December 31, 2026.

How is this Bausch & Lomb Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208078055. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 3.5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24208-780-55
11-Digit CMS (5-4-2)
24208-0780-55

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.